Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood pressure, calcium channel blockers, and the risk of prostate cancer: a Mendelian randomization study.

Cancer causes & control : CCC - 1 Aug 2023

Kazmi Nabila, Valeeva Elena V, Khasanova Gulshat R, Lewis Sarah J, Plotnikov Denis

Abstract excerpt

BACKGROUND: Observational studies have found some evidence of an association between elevated blood pressure and prostate cancer risk; however, the results are inconclusive. We tested whether systolic blood pressure (SBP) influences prostate cancer risk and evaluated the effect of calcium channel blockers (CCB) on the disease using Mendelian randomization (MR) approach. METHODS: We used 278 genetic variants...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Pressure
Share to Calcium Channel Blockers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Causality

Share to Genome-Wide Association Study

Share to Mendelian Randomization Analysis

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 37178364
DOI: 10.1007/s10552-023-01712-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood pressure, calcium channel blockers, and the risk of prostate cancer: a Mendelian randomization study.PMID 37178364Read ↗

Blood pressure and bladder cancer risk in men by use of survival analysis and in interaction with NAT2 genotype, and by Mendelian randomization analysis.Semantic proximity Read ↗

Exploring the Associations and Mechanisms Between Antihypertensive Drugs and Urological Tumors: Insights from a Mendelian Randomization Study.Semantic proximity Read ↗

Causal relationship between prostatic diseases and prostate cancer: a mendelian randomization study.Semantic proximity Read ↗

Exploring the causal relationship: bidirectional mendelian randomization study on benign prostatic hyperplasia and cardiovascular diseasesSemantic proximity Read ↗

Appraising causal relationships of dietary, nutritional and physical-activity exposures with overall and aggressive prostate cancer: two-sample Mendelian-randomization study based on 79 148 prostate-cancer cases and 61 106 controlsSemantic proximity Read ↗

Genetic proxies for calcium channel blockers and cancer: a Mendelian randomization study.Semantic proximity Read ↗

Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.Semantic proximity Read ↗

Antihypertensive drug targets and breast cancer risk: a two-sample Mendelian randomization study.Semantic proximity Read ↗

[Inflammatory factors and prostate cancer: Two-sample Mendelian randomization analysis].Semantic proximity Read ↗

The causal association between systolic blood pressure and breast cancer: a two sample Mendelian randomization study.Semantic proximity Read ↗

Systemic lupus erythematosus and prostate cancer risk: a pool of cohort studies and Mendelian randomization analysis.Semantic proximity Read ↗

Prostatitis, benign prostatic hyperplasia, and prostate cancer: a bidirectional Mendelian randomization study and clinical implications for these patients' populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.